Evidence map›Paper›PMID 42277024›Full record

ArticleNature communications2026

Bone-derived Osterix+ osteolineage cells are a source of tumor-promoting myofibroblastic cancer-associated fibroblasts in breast cancer.

Giulia Furesi, Carisa Zeng, Emily M Eul, Jennifer Zarrer, Deborah J Veis, Jiayu Ye, Vasilios A Morikis, Taylor Malachowski, Darya Khantakova, Alina Ulezko Antonova and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Giulia FuresiDepartment of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Carisa ZengDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID http://orcid.org/0000-0002-7108-3873
Emily M EulDepartment of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Jennifer ZarrerInstitute of Musculoskeletal Medicine, Musculoskeletal University Center Munich, University Hospital, LMU Munich, Munich, Germany.ORCID http://orcid.org/0009-0003-4264-2933
Deborah J VeisDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID http://orcid.org/0000-0001-7101-5582
Jiayu YeDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Vasilios A MorikisDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Taylor MalachowskiDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, USA.
Darya KhantakovaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID http://orcid.org/0000-0002-2579-5140
Alina Ulezko AntonovaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Anupama MelamDepartment of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID http://orcid.org/0000-0002-1000-5273
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID http://orcid.org/0000-0001-5222-4987
Eric HesseInstitute of Musculoskeletal Medicine, Musculoskeletal University Center Munich, University Hospital, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-2778-7208
Hanna TaipaleenmäkiInstitute of Musculoskeletal Medicine, Musculoskeletal University Center Munich, University Hospital, LMU Munich, Munich, Germany.ORCID http://orcid.org/0000-0002-8254-9333
Gregory D LongmoreDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID http://orcid.org/0000-0001-7568-8151
Sheila A StewartDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID http://orcid.org/0000-0002-2260-9576
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID http://orcid.org/0000-0002-1133-4212
Roberta FaccioDepartment of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA. faccior@wustl.edu.ORCID http://orcid.org/0000-0003-1639-2005

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Jeffrey Wade Brown · 2000 to 2026
$30.8M
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)P30AR074992 · NIAMS · WASHINGTON UNIVERSITY · PI MATTHEW J SILVA · 2019 to 2026
$6.8M
The Role of the Osteoblast Secretome in Bone FormationP30AR057235 · NIAMS · WASHINGTON UNIVERSITY · PI SWARNKAR, GAURAV · 2009 to 2018
$5.7M
Novel Regulators of Inflammatory Arthritis and Bone ErosionR01AR066551 · NIAMS · WASHINGTON UNIVERSITY · PI FACCIO, ROBERTA · 2015 to 2020
$2.0M
Role of Bone in Primary and Metastatic CancerR01CA235096 · NCI · WASHINGTON UNIVERSITY · PI FACCIO, ROBERTA · 2020 to 2024
$1.8M
Role of Osterix+ Osteolineage Cells in Primary and Metastatic Breast CancerR01CA270030 · NCI · WASHINGTON UNIVERSITY · PI Roberta Faccio · 2023 to 2026
$1.7M
Regulation of hematopoiesis during tumor progressionF31CA284858 · NCI · WASHINGTON UNIVERSITY · PI EUL, EMILY M · 2023 to 2025
$146k
Alternative NF-KB as a negative regulator of osteogenesisF31AR068853 · NIAMS · WASHINGTON UNIVERSITY · PI DAVIS, JENNIFER LYNN · 2015 to 2017
$91k
NCI NIH HHS F31 CA284858NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA235096NCI NIH HHS R01 CA270030NIAMS NIH HHS F31 AR068853NIAMS NIH HHS P30 AR057235NIAMS NIH HHS P30 AR074992NIAMS NIH HHS R01 AR066551NIDDK NIH HHS P30 DK052574U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA235096U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA270030U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) R01AR066551
6 · The paper itself

Abstract

Cancer-associated fibroblasts (CAFs) are major regulators of breast cancer (BC) progression and therapeutic resistance, yet the extent to which CAF heterogeneity is dictated by distinct cellular origins remains unresolved. Here, we identify bone-derived Osterix

Indexed as

Bone and BonesBreast NeoplasmsCancer-Associated FibroblastsMyofibroblastsSp7 Transcription FactorAnimalsCell DifferentiationCell Line, TumorExtracellular MatrixFemaleGene Expression Regulation, NeoplasticHumansMiceSP7 protein, humanSp7 protein, mouseSp7 Transcription Factor

Identifiers

PMID42277024
PMCPMC13408961

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.